Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Apr 15, 2020; 12(4): 365-382
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.365
Published online Apr 15, 2020. doi: 10.4251/wjgo.v12.i4.365
Figure 2 The effects of hybrids (HGC-27 or SGC-7901 fused with mesenchymal stem cells) on gastric cancer[60].
A: The morphology of the two gastric cancer cell lines, hUCMSCs, HGC-27 fusion, and SGC-7901 fusion; B: The growth of the parental and hybrid cells was determined by cell counting assay; C: The expression of PCNA and CyclinD1 proteins in different groups; D: Representative images of the gastric tumor bearing mice; E: The images of the tumor tissues; F: Tumor weight; and G: Tumor volume. hUCMSCs: Human umbilical cord mesenchymal stem cells; PCNA: Proliferating cell nuclear antigen.
- Citation: Li JN, Li W, Cao LQ, Liu N, Zhang K. Efficacy of mesenchymal stem cells in the treatment of gastrointestinal malignancies. World J Gastrointest Oncol 2020; 12(4): 365-382
- URL: https://www.wjgnet.com/1948-5204/full/v12/i4/365.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i4.365